林麗凡


【摘要】 目的:研究糜爛型口腔扁平苔蘚應用他克莫司治療的效果、不良反應發生率和復發率等。方法:將2015年1月-2016年4月筆者所在醫院確診的70例糜爛型口腔扁平苔蘚患者隨機納入觀察組(他克莫司軟膏)和對照組(丙酸氯倍他素軟膏)中,每組35例,觀察記錄所有患者的臨床療效、不良反應發生率和復發率等。結果:觀察組患者的治療總有效率、不良反應發生率、復發率比較,差異無統計學意義(P>0.05)。結論:他克莫司和丙酸氯倍他素在糜爛型口腔扁平苔蘚的治療中具有高效安全的特點,可在治療中交替使用,其臨床應用價值較高。
【關鍵詞】 他克莫司; 丙酸氯倍他素; 糜爛型口腔扁平苔蘚; 臨床效果
doi:10.14033/j.cnki.cfmr.2017.6.006 文獻標識碼 B 文章編號 1674-6805(2017)06-0010-03
Clinical Efficacy Observation of Tacrolimus in the Treatment of Erosive Oral Lichen Planus/LIN Li-fan.//Chinese and Foreign Medical Research,2017,15(6):10-12
【Abstract】 Objective:To explore the clinical efficacy,incidence of adverse reactions and recurrence rate about the treatment of oral lichen planus of erosive type with Tacrolimus.Method:Seventy patients with oral lichen planus of erosive type were regard as research group from January 2015 to April 2016 in our hospital which were divided into observation group(Tacrolimus Ointment) and control group(Clobetasol Propionate Cream) equally.The clinical efficacy,incidence of adverse reactions and recurrence rate of all the patients were observed and recorded.Result:The differences in the clinical efficacy,incidence of adverse reactions and recurrence rate between the two groups were not statistically significant(P>0.05).Conclusion:In the treatment of oral lichen planus of erosive type,Tacrolimus Ointment and Clobetasol Propionate Cream are both safe and effective with an ideal substitutability in the treatment,so their clinical application value are considerable.
【Key words】 Tacrolimus; Clobetasol Propionate; Oral lichen planus of erosive type; Clinical efficacy
First-authors address:Guangdong Hydropower Hospital,Guangzhou 511340,China
作為一種臨床上常見的皮膚黏膜慢性炎癥性疾病,口腔扁平苔蘚(Oral lichen planus, OLP)常以糜爛型的臨床癥狀出現且難以治愈,常在患者的唇部、頰部、舌腹、前庭溝或磨牙后區發生充血、水腫和糜爛等癥狀,病灶處可見丘疹、白色條紋,并伴有灼燒感[1]。目前,臨床上對于該病的發病機制尚不了解[2],發病概率僅次于復發性口腔潰瘍,尤以中年婦女患者為多,經長期研究發現[3],該病通常存在較明顯的惡變傾向,為此世界衛生組織特將其列為癌前狀態。臨床上該病的適用藥物包括有口腔潰瘍散、鹵米松和丙酸氯倍等,盡管有報道稱丙酸氯倍的臨床療效比常規藥物更好[4],但其也存在一定的用藥局限性,如用藥不良反應較多,疾病難以根治且復發率較高,此外還有他克莫司也被應用于該病的臨床治療中。本……